Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 23 Dec 2025 for IN8BIO, INC., €43k. Read the official filing
Filing timeline
BuySaleAlan S. Roemer
Insider track record
Disclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Alan S. Roemer: trading record in brief
This profile gathers the share dealings of Alan S. Roemer across 2 companies, led by In8bio, Inc. and NexImmune, Inc. In total, 7 filings cover trades dated from 21 December 2021 to 22 December 2025.
Market trades split into 1 purchase (€49k) and 1 sale. The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 share grants and 2 option exercises.
On 23 December 2025 came the latest disclosure, a share grant for €43k in In8bio, Inc. The last purchase on record was published on 18 August 2022, which is 1,522 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alan S. Roemer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
36,232 shares@ US$1.3839.3% of flowCommon StockSEC:0001643070-25-000005:0
102,459 shares@ US$0.184425.3% of flowCommon StockSEC:0001415889-25-012287:0
126,582 sharesCommon StockSEC:0001415889-24-024868:0
102,459 sharesCommon StockSEC:0001209191-23-058719:0
3,833 shares@ €1.975312.3% of flowCommon StockSEC:0001209191-23-056514:0
26,315 shares@ US$1.9074.7% of flowCommon StockSEC:0001209191-22-046600:0
Canonical exit: 14 Nov 2022 (T+90)
12,634 shares@ €2.145950.0% of flowCommon StockSEC:0001209191-21-070944:0
7 of 7 declarations
